NEWTOWN, Pa.--(BUSINESS WIRE)--Quinnova Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and markets novel topical delivery platform-based prescription drugs, today announced the launch of its NEOSALUSTM CREAM. NEOSALUS CREAM, the latest addition to Quinnova’s NEOSALUS brand, is a prescription product with anti-inflammatory properties that can be used without age or long-term use restrictions for the treatment of a variety of chronic inflammatory skin conditions like atopic dermatitis, contact dermatitis, and hand eczema. The non-irritating cream is gentle, safe, and fragrance- and alcohol-free. Using the Proderm Technology Delivery System (“Proderm”), NEOSALUS CREAM complements Quinnova’s NEOSALUS product line.
